Research programme: amyloid precursor protein secretase inhibitors - Bristol-Myers SquibbAlternative Names: BMS-289948; BMS-299897; BMS-433796
Latest Information Update: 12 Nov 2013
At a glance
- Originator Bristol-Myers Squibb
- Class Amides; Benzodiazepines; Benzodiazepinones
- Mechanism of Action Amyloid precursor protein secretase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease